| Structure |
Chemical Name |
CAS |
MF |
 |
Prednisolone Impurity A |
77017-17-5 |
C21H26O5 |
 |
Rivaroxaban Impurity 61 |
1643354-27-1 |
C32H30N4O8 |
 |
Rivaroxaban Impurity 74 |
|
|
|
|
Sitafloxacin Impurity 6 |
|
|
|
|
Ticagrelor Related Compound 75 |
|
|
 |
Ticagrelor Related Compound 93 |
2207528-55-8 |
C23H28F2N6O4S |
 |
Vonoprazan Impurity 24 |
1807642-41-6 |
C16H14FN3O2S |
|
|
Vonoprazan Impurity 35 |
|
|
|
|
Blonanserin Impurity L |
|
|
|
|
Cefazolin USP Impurity E |
|
|
|
|
Exemestane Impurity 5 |
|
|
 |
Medetomidine Impurity 28 |
2240179-64-8 |
C23H28N2 |
 |
Peramivir Impurity 4 |
229615-12-7 |
C15H28N4O4 |
|
|
Peramivir Impurity 9 |
|
|
|
|
PidotimodImpurity T |
|
|
 |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2093243-16-2 |
C17H13NO4 |
|
|
Lenvatinib Impurity 10 |
|
|
|
|
Nifuratel Impurity 10 |
|
|
 |
Ozagrel Impurity 16 |
143945-86-2 |
C13H12N2O2 |
|
|
Tofacitinib Impurity 68 |
|
|
![2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid](/CAS/20200119/GIF/123185-91-1.gif) |
2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid |
123185-91-1 |
C9H14O5 |
 |
5-(3-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3- carbaldehyde |
|
C16H11FN2O3S |
 |
Dapoxetine impurity |
126113-24-4 |
C19H16O2 |
 |
Loratadine Impurity 17 |
133330-72-0 |
C14H12ClNO |
|
|
Prasugrel Impurity 11 |
|
|
|
|
Trelagliptin Impurity 18 |
|
|
 |
Ropivacaine impurity |
1786560-34-6 |
C12H14N2O3 |
 |
N-((3-(5-methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide |
|
C22H23N3O7S2 |
 |
(2R)-フェニルシクロペンチルヒドロキシ酢酸 |
64471-45-0 |
C13H16O3 |
|
|
2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole |
|
|
![(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran)](/CAS/20200119/GIF/CB14713877.gif) |
(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran) |
|
C34H32Cl2O4 |
 |
4-(1,3,2-Dioxaborinan-2-yl)benzonitrile |
152846-62-3 |
C10H10BNO2 |
 |
Rasagiline Impurity 5 Mesylate |
1312077-04-5 |
C13H15NO4S |
 |
Ibrutinib Dimer Impurity |
2031255-23-7 |
C50H48N12O4 |
 |
Rifaximin EP Impurity H |
1210022-90-4 |
C43H51N3O12 |
 |
Voriconazole (2R,3R)-Isomer |
137234-76-5 |
C16H13ClF3N5O |
 |
Diquafosol Impurity 12 |
694434-51-0 |
C18H26N4O23P4 |
 |
Etoricoxib Impurity 39 |
107825-28-5 |
C13H17NOS2 |
 |
Furosemide Impurity 7 |
4753-68-8 |
C5H8ClNO |
 |
Irinotecan Impurity 24 |
802277-44-7 |
C13H24N2O2 |
 |
Pyridoxine Impurity 12 |
58947-70-9 |
C8H9NO3 |
 |
Thiamine |
6309-04-2 |
C13H20Br2N4OS |
 |
1,1'-(1,4,8,11-tetraazacyclotetradecane-1,4-diyl)bis(2,2,2- trifluoroethan-1-one) dihydrochloride |
|
C14H24Cl2F6N4O2 |
|
|
Empagliflozin Impurity 40 |
|
|
|
|
Empagliflozin Impurity 46 |
|
|
![Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester](/CAS/20200119/GIF/153900-96-0.gif) |
Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester |
153900-96-0 |
C27H48O7 |
 |
pranoprofen |
143436-36-6 |
C17H19NO4 |
![2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile](/CAS/20200119/GIF/906673-30-1.gif) |
2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile |
906673-30-1 |
C14H10BNO3 |
 |
Fluconazole Impurity 5 |
154534-83-5 |
C10H9ClF2N4O |
 |
Fexofenadine N-Oxide |
1422515-52-3 |
C32H39NO5 |
 |
Trimetazidine Impurity 16 |
118709-62-9 |
C13H16O4 |
 |
Ortho-Isomer of Dapagliflozin |
2040305-05-1 |
C21H25ClO6 |
 |
Imidafenacin Related Compound 9 |
170105-17-6 |
C21H21N3 |
|
|
Cefminox Sodium impurity 1 |
|
|
|
|
Dapagliflozin Impurity 5 |
|
|
|
|
Emtricitabine Impurity E |
|
|
 |
Furosemide Impurity 4 |
|
C12H11ClN2O5S |
|
|
Pitavastatin Impurity 43 |
|
|
 |
Tazobactam Impurity B |
158411-82-6 |
C6H11NO3S |
|
|
Tirofiban Impurity E |
|
|
|
|
Tofacitinib Impurity 73 |
|
|
![(2R,3R)-2-アミノ-3-[4-(メチルスルホニル)フェニル]-1,3-プロパンジオール](/CAS/GIF/51458-28-7.gif) |
(2R,3R)-2-アミノ-3-[4-(メチルスルホニル)フェニル]-1,3-プロパンジオール |
51458-28-7 |
C10H15NO4S |
 |
21-(アセチルオキシ)-16α,17-ジヒドロキシプレグナ-1,4,9(11)-トリエン-3,20-ジオン |
77017-20-0 |
C23H28O6 |
 |
Pyrimidine, 4-chloro-5-nitro-2-(propylthio)- |
2518331-26-3 |
C7H8ClN3O2S |
|
|
Oseltamivir Impurity 110 |
|
|
|
|
Oseltamivir Impurity 108 |
|
|
|
|
Oseltamivir Impurity 102 |
|
|
 |
1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)- |
2606144-45-8 |
C16H18N6O |
 |
4-Piperidinecarboxylic acid, 1-(4-pyridinylcarbonyl)-, ethyl ester |
252263-38-0 |
C14H18N2O3 |
 |
1,4-ビス(4-ニトロフェニル)ピペラジン |
16264-05-4 |
C16H16N4O4 |
 |
ビス(2,4-キシリル)ペルスルフィド |
13616-83-6 |
C16H18S2 |
 |
バモロロン |
13209-41-1 |
C22H28O4 |
![N-[(6-アミノ-1,2,3,4-テトラヒドロ-1,3-ジメチル-2,4-ジオキソピリミジン)-5-イル]ホルムアミド](/CAS/GIF/7597-60-6.gif) |
N-[(6-アミノ-1,2,3,4-テトラヒドロ-1,3-ジメチル-2,4-ジオキソピリミジン)-5-イル]ホルムアミド |
7597-60-6 |
C7H10N4O3 |
![3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2374700-40-8.gif) |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
2374700-40-8 |
C16H20N6O |
![7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI)](/CAS/20210305/GIF/129815-82-3.gif) |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI) |
129815-82-3 |
C18H20FN3O4 |
![Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]-](/CAS/20210305/GIF/769083-63-8.gif) |
Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]- |
769083-63-8 |
C19H24N2O |
 |
N,N'-ジイソプロピル尿素 |
4128-37-4 |
C7H16N2O |
![Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester](/CAS/20210305/GIF/141354-54-3.gif) |
Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester |
141354-54-3 |
C9H9BrN2O3 |
|
|
monocalcium mono((3R,5S,E)-7-(4-(3-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
|
|
Cefradine Impurity J |
|
|
|
|
Peramivir diacetyl impurity 1 |
|
|
|
|
Urapidil Impurity 17 |
|
|
|
|
Clindamycin Impurity 86 |
|
|
|
|
Canagliflozin Impurity 77 |
|
|
|
|
Carbazochrome Sodium Sulfonate Impurity I |
|
|
|
|
Tadalafil impurities 45 |
|
|
|
|
Posaconazole Impurities 10 Complete Set |
|
|
 |
Warfarin Impurity 1 |
55901-61-6 |
C13H14O |
 |
Macitentan impurity B |
441796-13-0 |
C18H18Br2N6O4S |
|
|
Meropenem IMP B |
|
|
 |
4-(6-ブロモピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
412348-27-7 |
C14H20BrN3O2 |
![(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180703/GIF/1012341-56-8.gif) |
(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-56-8 |
C23H29NO4 |
 |
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |
 |
Parecoxib Impurity C |
3026677-40-4 |
|
 |
RAC アトモキセチン塩酸塩 |
82857-40-7 |
C17H22ClNO |
 |
3-(1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
943320-48-7 |
C10H8F3N3 |
 |
Linagliptin Impurity H |
1646355-34-1 |
C22H23N7O2 |
 |
Ezetimibe Impurity 54 |
1185883-39-9 |
C40H36F2N2O5 |
 |
2-(2-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
1348664-75-4 |
C13H13FN6O |
|
|
Dapagliflozin Impurity 2 |
|
|